iMeds.se

Salbutamol Sandoz


Package leaflet: Information for the user


Salbutamol Sandoz 100 micrograms/dose pressurised inhalation, suspension


Salbutamol


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.


What is in this leaflet:

1. What Salbutamol Sandoz is and what it is used for

2. What you need to know before you use Salbutamol Sandoz

3. How to use Salbutamol Sandoz

4. Possible side effects

5. How to store Salbutamol Sandoz

6. Contents of the pack and other information

1. What Salbutamol Sandoz is and what it is used for


Salbutamol Sandoz is used to treatbreathing difficulties caused by the following diseases:

- chronic bronchitis

- emphysema


Salbutamol Sandoz is additionally used to prevent asthma symptomscaused by:


Salbutamol Sandoz expands the airways, allowing the air to flow more freely. Salbutamol Sandoz should primarily be used to relieve symptoms rather than as a regular treatment.


Salbutamol Sandoz is indicated for adults, adolescent and children from 4 to 11 years.


2. What you need to know before you use Salbutamol Sandoz

Do not use Salbutamol Sandoz

if you are allergic to salbutamol or any of the other ingredients of this medicine (listed in section 6).


Warnings and precautions

Talk to your doctor before using Salbutamol Sandoz if any of the following conditions apply to you:


Other medicines and Salbutamol Sandoz

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.


The following medicines can influence or be influenced by Salbutamol Sandoz:

heart and vascular medicines which can narrow the airways and containing active substances ending in “-ol” such as propranolol (betablockers)

This may cause spasms in the lung airways.

certain medicines to treat depression:

monoamine oxidase inhibitors (e.g. moclobemide)

tricyclic antidepressants, such as amitriptyline



Pregnancy and breast-feeding

Limited knowledge exists regarding use during pregnancy, but there is also a risk for the unborn child, if your asthma is untreated during pregnancy. Therefore, you should use Salbutamol Sandoz only if your doctor indicates it is clearly necessary. Do not change the dosage by yourself, but always use it according to your doctor’s recommendation.


It is unknown, whether salbutamol passes into the mother´s milk. Therefore, only use Salbutamol Sandozif your doctor indicates it is clearly necessary.


If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


Driving and using machines

No studies on the effects on the ability to drive and use machines have been performed. Therefore, do not drive or operate machines until you know how the medicine is affecting you.


3. How to use Salbutamol Sandoz

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is:


Adults and adolescents aged 12 years and over

Relief of attacks:

1-2 inhalations as required.

prevent symptoms caused by exercise or triggers:

2 inhalations 10-15 minutes beforehand


Maximum dosage: 8 inhalations per day.


Children (4-11 years)

Relief of attacks:

1 inhalation as required. The dose may be increased to two inhalations if required.

symptoms caused by exercise or triggers:

1 inhalation, or 2 if necessary 10-15 minutes beforehand


Maximum dosage: 8 doses per day.


Children below 4 years of age

No recommendations can be made for dosage since the effect has not yet been determined.


Contact your doctor if the treatment is not effective enough or if you need more doses per day than usual. Never increase your dose or change the duration of use without your doctor´s approval.


Inhaler test before use:

Check that the inhaler is functioning, if you use a new inhaler or if it has not been used for 7 days or more. Remove the protective cap, shake the inhaler and spray twice into the air.


Instructions for use:

Inhale sitting or standing, wherever possible.


Remove the protective cap. Check inside and outside to make sure that the mouthpiece is clean.


Shake the inhaler thoroghly for a couple of seconds before use.


Hold the inhaler upright with the bottom of the container upwards, put your thumb on the base, below the mouthpiece. Breathe out as far as is comfortable, but do not breathe into the mouthpiece.


Place the mouthpiece in your mouth between your teeth and close your lips around it but do not bite it.


Just after starting to breathe in through your mouth press down on the top of the inhaler to release a puff while still breathing in steadily and deeply.


Hold your breath for 5-10 seconds. Take the inhaler from your mouth and your finger from the top of the inhaler.


If you need another puff keep the inhaler upright and wait about half a minute before repeating steps 2 to 6.


After use always replace the mouthpiece cover to keep out dust and fluff. Replace mouthpiece cover firmly and snap into position.

Some people find it difficult to release a puff of medicine just after they start to breathe in. In this case, as well as for children, the Vortex® or AeroChamber® Plus spacer device can be used. Please refer to the product information of the spacer device for its correct handling.


Cleaning

To prevent the inhaler blocking up or if it does block up, clean it at least once a week, as follows:


Pull the metal canister out of the plastic case of the inhaler and remove the mouthpiece cover.

Rinse the plastic case and the mouthpiece cover in lukewarm water. Do not attempt to remove any build up of medicine around the mouthpiece with a sharp object, such as a pin. A mild detergent may be added to the water, then rinse thoroughly with clean water before drying. Do not put the metal canister into water.

Leave the plastic case and the mouthpiece cover to dry in a warm place. Avoid excessive heat.

Replace the canister and mouthpiece cover.


Inhaler content:

Shake the spray to check the remaining amount of medicine in your inhaler. Do not use Salbutamol Sandoz if you do not detect any liquid in the inhaler while shaking.


Cold temperature use:

If the inhaler has been stored beneath 0 °C, warm it in your hands for 2 minutes, shake it and spray into the air twice before use.


If you use more Salbutamol Sandoz than you should

In this case always contact your doctor or hospital.


Typical symptoms of overdose are:


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.


Stop using Salbutamol Sandoz and contact your doctorimmediately if you develop any of the following:

allergic reaction symptoms such as

chest pain, see under „Frequency not known” below

breathing immediately becomes worse after taking Salbutamol Sandoz, although Salbutamol Sandoz reduces symptoms. This may mean your disease is worsening and other treatment is urgently needed.


Side effects can occur with the following frequencies:


Common, may affect up to 1 in 10 people:


Uncommon, may affect up to 1 in 100 people:


Rare, may affect up to 1 in 1,000 people:


Very rare, may affect up to 1 in 10,000 people:


Not known (the frequency cannot be estimated from the available data)

Although it is not known exactly how often this happens, some people may occasionally experience chest pain (due to heart problems such as angina). Tell your doctor if you develop these symptoms whilst receiving treatment with Salbutamol Sandoz, but do not stop using this medicine unless told to do so.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Salbutamol Sandoz

Keep this medicine out of the sight and reach of children Do not store above 30 °C.


Store the inhaler lying flat or in an inverted position, with the mouthpiece pointing downward.


The canister contains a pressurized liquid. Do not expose to temperatures higher than 50° C, even for a short period of time. Protect from heat, direct sunlight and frost! Do not pierce or burn the canister.even when empty


Do not use Salbutamol Sandoz after the expiry date which is stated on the label and carton. The expiry date refers to the last day of that month.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.


6. Contents of the pack and other information

What Salbutamol Sandozcontains

The active substance is salbutamol.

One metered dose contains 100 micrograms salbutamol (as sulphate).

The delivered dose through the mouthpiece is 90 micrograms of salbutamol (as sulphate).

The delivered dose through the mouthpiece is 108 micrograms salbutamol sulphate equivalent to 90 micrograms salbutamol.


The other ingredients are norflurane (HFA134a), anhydrous ethanol, oleic acid


What Salbutamol Sandozlooks like and contents of the pack

This medicinal product is a white pressurised inhalation suspensioninaluminium containers with metering valve and plastic applicator.


Packs containing

200 metered doses equal to 8.5 g pressurised inhalation, suspension.


2 x 200 metered doses equal to 2 x 8.5 g pressurised inhalation, suspension.


3 x 200 metered doses equal to 3 x 8.5 g pressurised inhalation, suspension.


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


[To be completed nationally]


{Name and address}

<{tel}>

<{fax}>

<{e-mail}>


This medicinal product is authorised in the Member States of the EEA under the following names:


{Name of the Member State} {Name of the medicinal product}

[to be completed nationally]


This leaflet was last revised in 2015-11-23


[To be completed nationally]